Here is a comprehensive overview of the drugs that act on the central and peripheral nervous systems. This volume thoroughly describes the diseases associated with the nervous system and the drugs used for their treatment while also looking at the current status of these drugs and their future potential and challenges. Divided into three sections, the book first focuses on the drugs that affect the functions of the autonomic nervous system to produce therapeutic effects. These drugs may act presynaptically by manipulating the genesis, storage, and secretion, and by blocking the action of neurotransmitters. Some drugs may trigger or impede postsynaptic receptors. Section 2 focuses on drugs that affect the central nervous system, including antianxiety drugs, sedative and hypnotic drugs, antidepressant drugs, antipsychotic drugs, antiepileptic drugs, and many more. It covers the pharmacological management of various diseases, including Alzheimer’s, Parkinson’s, Huntington’s, and others. The last section offers explanations of neurochemical interactions with the aim to develop drugs that have beneficial effects on neurochemical imbalances. This section demonstrates models to assess the transport of drugs across the blood-brain barrier and nanomedicine to treat brain disorders. This rich compilation provides thorough and extensive research updates on the important advances in neuropharmacological drugs and drug therapy from experienced and eminent academicians, researchers, and scientists from throughout the world.

This volume of International Review of Neurobiology brings together cutting-edge research on advances in the neurochemistry and neuropharmacology of Tourette syndrome. It reviews current knowledge and understanding, provides a starting point for researchers and practitioners entering the field, and includes important topics regards tics, neurotransmitters, pharmacology and emerging treatments. - This volume of brings together research on tourettes synrdrome. It reviews current knowledge and understanding on the neurochemistry and neuropharmacology of tourettes syndrome

Advances in Pharmacology

In the field of pharmaceutical sciences, the integration of artificial intelligence (AI) has emerged as a groundbreaking force, propelling the field into uncharted territories of discovery and innovation. As traditional approaches in drug discovery and development encounter new challenges, the need for cutting-edge technologies becomes increasingly apparent. AI-Powered Advances in Pharmacology offers an insightful exploration of this critical intersection between AI and pharmacological research. This book delves into how AI technologies are reshaping the understanding of diseases, predicting drug responses, and optimizing therapeutic interventions. It navigates through the relationship between AI algorithms, big data analytics, and traditional pharmacological methodologies, promising to accelerate drug development and usher in a new era of precision medicine. The primary objective of AI-Powered Advances in Pharmacology is to conduct a thorough exploration of the integration of artificial intelligence (AI) into pharmacological research, shedding light on its transformative impact on drug discovery, development, and personalized medicine. This comprehensive overview aims to serve as a valuable resource for researchers, practitioners, and students in the field, bridging the gap between traditional pharmacological approaches and AI methodologies. Through case studies and discussions of emerging trends, the book contributes to the evolving landscape of pharmacology, fostering a deeper understanding of diseases, optimizing therapeutic interventions, and shaping the future of precision medicine. By providing practical insights, it aims to inspire further advancements at the intersection of artificial intelligence and pharmacology.

Advances in Pharmacology and Chemotherapy

Issues for 1977-1979 include also Special List journals being indexed in cooperation with other institutions. Citations from these journals appear in other MEDLARS bibliographies and in MEDLING, but not in Index medicus.

First multi-year cumulation covers six years: 1965-70.